These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6824563)

  • 41. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
    Kawasaki H
    Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction between centrally acting hypotensive drugs and tricyclic antidepressants.
    van Zwieten PA
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):12-30. PubMed ID: 1156022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacology of centrally acting hypotensive drugs.
    van Zwieten PA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):13S-20S. PubMed ID: 6104975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function.
    Harron DW; Hasson B; Regan M; McClelland RJ; King DJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S48-54. PubMed ID: 8642806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.
    Curran HV; Lader M
    Eur J Clin Pharmacol; 1986; 29(5):601-7. PubMed ID: 3082644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of amitriptyline and mianserin on psychomotor skills and memory in man.
    Mattila MJ; Liljequist R; Seppälä T
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):53S-55S. PubMed ID: 341944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of mianserin and yohimbine on presynaptic alpha 2-receptors].
    Carvajal García-Pando A; González Martínez de Zárate JL; Velasco Martín A
    Arch Farmacol Toxicol; 1983 Apr; 9(1):21-8. PubMed ID: 6312903
    [No Abstract]   [Full Text] [Related]  

  • 49. Centrally acting antihypertensive agents: a brief overview.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S803-7. PubMed ID: 6084129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Centrally acting antihypertensive agents (author's transl)].
    Elghozi JL; Grünfeld JP
    Therapie; 1982; 37(2):163-9. PubMed ID: 7112486
    [No Abstract]   [Full Text] [Related]  

  • 51. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.
    Clough DP; Hatton R
    Br J Pharmacol; 1981 Jul; 73(3):595-604. PubMed ID: 6113864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antihypertensive methyldopa, labetalol, hydralazine, and clonidine reversed tumour necrosis factor-α inhibited endothelial nitric oxide synthase expression in endothelial-trophoblast cellular networks.
    Xu B; Bobek G; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):421-427. PubMed ID: 27998008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Oral premedication with clonidine as an alternative in dental practice. The effects on the pain threshold, blood pressure and salivary flow].
    Fanini D; Poglio M; Marci MC; Iovinelli G; Antenucci F
    Minerva Stomatol; 1998 Sep; 47(9):453-64. PubMed ID: 9835755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of single and multiple doses of guanfacine in essential hypertension.
    Zamboulis C; Reid JL
    Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitors.
    Kersting F; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):547-55. PubMed ID: 322921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the actions of centrally and peripherally administered clonidine and guanfacine in the rabbit: investigation of the differences.
    Barber ND; Reid JL
    Br J Pharmacol; 1982 Dec; 77(4):641-7. PubMed ID: 6758908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modification by antihypertensive drugs of amphetamine-induced stereotypy in rats.
    van Dorsser W; Roba J
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):326-8. PubMed ID: 575615
    [No Abstract]   [Full Text] [Related]  

  • 59. The clinician's guide to pharmacology of antihypertensive agents.
    Gottlieb TB; Chidsey CA
    Geriatrics; 1976 Jan; 31(1):99-110. PubMed ID: 1107149
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of ethanol on reductions in norepinephrine electrochemical signal in the rostral ventrolateral medulla and hypotension elicited by I1-receptor activation in spontaneously hypertensive rats.
    Mao L; Li G; Abdel-Rahman AA
    Alcohol Clin Exp Res; 2003 Sep; 27(9):1471-80. PubMed ID: 14506409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.